Nova Patents
AT339975T

Anti-angiogenic compositions and methods of use

Abstract

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Term

Term ended

Expired 19 July 2014, 12.2 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

178 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
9453693United States of AmericaA

Members178

Family members, oldest first
DocumentOfficeKind
CA2167268A1CanadaA1
CA2468375A1CanadaA1
CA2472373A1CanadaA1
CA2472404A1CanadaA1
WO9503036A1World Intellectual Property Organization (WIPO)A1
AU7119294AAustraliaA
NO960226D0NorwayD0
NO20073066LNorwayL
NO960226LNorwayL
EP0706376A1European Patent Office (EPO)A1
CN1130866AChinaA
JPH09503488AJapanA
EP0706376B1European Patent Office (EPO)B1
AT154757TAustriaT
ATE154757T1AustriaT1
DE69403966D1GermanyD1
EP0797988A2European Patent Office (EPO)A2
DK0706376T3DenmarkT3
ES2106553T3SpainT3
NZ268326ANew ZealandA
GR3024833T3GreeceT3
DE69403966T2GermanyT2
US5716981AUnited States of AmericaA
AU693797B2AustraliaB2
US5886026AUnited States of AmericaA
US5994341AUnited States of AmericaA
EP0797988A3European Patent Office (EPO)A3
NZ329193ANew ZealandA
EP1155689A2European Patent Office (EPO)A2
EP1155690A2European Patent Office (EPO)A2
EP1155691A2European Patent Office (EPO)A2
EP1155689A3European Patent Office (EPO)A3
EP1155690A3European Patent Office (EPO)A3
EP1159974A1European Patent Office (EPO)A1
EP1159975A2European Patent Office (EPO)A2
EP1159975A3European Patent Office (EPO)A3
RU2180844C2Russian FederationC2
EP1155691A3European Patent Office (EPO)A3
HK1042054A1Hong Kong, ChinaA1
US2002119202A1United States of AmericaA1
US2002164377A1United States of AmericaA1
US2002165265A1United States of AmericaA1
JP2002326930AJapanA
US2003003094A1United States of AmericaA1
US2003004209A1United States of AmericaA1
US6506411B2United States of AmericaB2
US6544544B2United States of AmericaB2
JP3423317B2JapanB2
RU2001132111ARussian FederationA
NZ511762ANew ZealandA
KR100389223B1Republic of KoreaB1
US2003203976A1United States of AmericaA1
KR20030097620ARepublic of KoreaA
CN1138505CChinaC
US2004062810A1United States of AmericaA1
US2004076672A1United States of AmericaA1
CN1502331AChinaA
CA2167268CCanadaC
EP1155690B1European Patent Office (EPO)B1
AT277649TAustriaT
ATE277649T1AustriaT1
DE69434048D1GermanyD1
US6846841B2United States of AmericaB2
US2005042295A1United States of AmericaA1
NZ523799ANew ZealandA
US2005123605A1United States of AmericaA1
US2005208137A1United States of AmericaA1
DE69434048T2GermanyT2
CN1704121AChinaA
US2006034932A1United States of AmericaA1
US2006035830A1United States of AmericaA1
US2006035831A1United States of AmericaA1
US2006035832A1United States of AmericaA1
US2006035833A1United States of AmericaA1
NZ533467ANew ZealandA
EP1632259A2European Patent Office (EPO)A2
HK1079715A1Hong Kong, ChinaA1
EP1652539A1European Patent Office (EPO)A1
DK0706376T5DenmarkT5
US2006121117A1United States of AmericaA1
US2006127445A1United States of AmericaA1
EP1632259A3European Patent Office (EPO)A3
EP1695697A1European Patent Office (EPO)A1
EP1695698A1European Patent Office (EPO)A1
EP1155689B1European Patent Office (EPO)B1
AT339975TThis recordAustriaT
ATE339975T1AustriaT1
US2006240113A1United States of AmericaA1
DE69434856D1GermanyD1
DK1155689T3DenmarkT3
JP2006328086AJapanA
US2007003629A1United States of AmericaA1
US2007003630A1United States of AmericaA1
PT1155689EPortugalE
DE69434856T2GermanyT2
ES2267638T3SpainT3
JP2007084572AJapanA
CN100998565AChinaA
CN100998869AChinaA
EP1159974B1European Patent Office (EPO)B1
Showing 100 of 178